Chinese biotech shares are surging this year on growing optimism over innovative cancer treatments being licensed to western ...

This is an audio transcript of the FT News Briefing podcast episode: ‘Big Pharma markets left in a ‘patent cliff’-hanger’ ...

After Trump's announcement, Commerce Secretary Howard Lutnick told CNBC that details on pharmaceutical tariffs would come at ...

However, yesterday’s shock twist out of Washington could test just how tough Big Pharma really is, with health care stocks ...

Today’s settlement brings in millions of dollars to help Utah heal from this epidemic and ensures families see the justice ...

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into ...

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

Yahoo Finance Senior Reporter Anjalee Khemlani joins Morning Brief to discuss Merck's (MRK) pending $10 billion acquisition ...

Torrent Pharma’s ₹25,689-crore acquisition of JB Chemicals boosts its chronic portfolio and expands its global reach. But ...

Methode Electronics posted adjusted loss of 77 cents per share, missing market estimates of earnings of 4 cents per share, ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million public listing was fully subscribed on the second day of bidding, as investors bet on the company's growth prospects at a time when global big ...

What’s impacting medical affairs today is the update to drug approvals: there’s more visibility, more scrutiny, and more ...